[8-K] HEALTHSTREAM INC Reports Material Event
HealthStream, Inc. filed an 8-K reporting that on October 8, 2025 the company issued a press release announcing it acquired Virsys12, LLC, a Tennessee limited liability company. The filing states the press release is attached as Exhibit 99.1 and incorporated by reference. No financial terms, purchase price, or changes to management or guidance are disclosed in the filing. The document is limited to the announcement of the acquisition and the exhibit; it does not include financial statements or details about the transaction's expected impact on revenue, expenses, or operations.
HealthStream, Inc. ha presentato una 8-K che comunica che, l'8 ottobre 2025, la società ha emesso un comunicato stampa annunciando l'acquisizione di Virsys12, LLC, una società a responsabilità limitata del Tennessee. La compilazione indica che il comunicato stampa è allegato come Exhibit 99.1 e incorporato per riferimento. Nel filing non vengono divulgati termini finanziari, prezzo di acquisto o cambiamenti nella gestione o nelle linee guida. Il documento è limitato all'annuncio dell'acquisizione e all'esibizione; non include bilanci o dettagli sull'impatto previsto sulla redditività, sulle spese o sulle operazioni.
HealthStream, Inc. presentó un 8-K informando que el 8 de octubre de 2025 la empresa emitió un comunicado anunciando la adquisición de Virsys12, LLC, una sociedad de responsabilidad limitada de Tennessee. La presentación indica que el comunicado de prensa está adjunto como el Exhibit 99.1 e incorporado por referencia. En la presentación no se divulgan términos financieros, precio de compra ni cambios en la dirección o en las directrices. El documento se limita al anuncio de la adquisición y al exhibit; no incluye estados financieros ni detalles sobre el impacto esperado en ingresos, gastos u operaciones.
HealthStream, Inc.은 2025년 10월 8일에 회사가 보도자료를 발표하여 Virsys12, LLC를 인수했다고 발표하는 8-K를 제출했습니다. 이는 Tennessee 주의 유한책임회사입니다. 제출 자료는 보도자료가 Exhibit 99.1로 첨부되어 있으며 참조에 의해 통합되어 있음을 명시합니다. 서류에는 재무 조건, 매입가, 경영진 변경 또는 가이드라인의 변경이 공시되지 않았습니다. 문서는 인수 발표 및 첨부 문서에 한정되며, 재무제표나 거래가 매출, 비용 또는 운영에 미칠 예상 영향에 대한 세부사항은 포함되어 있지 않습니다.
HealthStream, Inc. a déposé un 8-K indiquant qu'le 8 octobre 2025 la société a publié un communiqué annonçant l'acquisition de Virsys12, LLC, une société à responsabilité limitée du Tennessee. Le dépôt précise que le communiqué de presse est joint en tant que pièce 99.1 et incorporé par référence. Aucune condition financière, prix d'achat ou changement de direction ou d'orientation n'est divulgué dans le dépôt. Le document se limite à l'annonce de l'acquisition et à la pièce jointe; il ne comprend pas les états financiers ni les détails sur l'impact prévu sur les revenus, les dépenses ou les opérations.
HealthStream, Inc. hat eine 8-K eingereicht, in der am 8. Oktober 2025 ein Pressemitteilung veröffentlicht wurde, die den Erwerb von Virsys12, LLC, einer Tennessee Limited Liability Company, ankündigt. Die Einreichung gibt an, dass die Pressemitteilung als Exhibit 99.1 beigefügt und durch Bezugnahme aufgenommen ist. Im Filing werden keine finanziellen Bedingungen, kein Kaufpreis oder Änderungen an der Geschäftsführung oder dem Guidance offengelegt. Das Dokument beschränkt sich auf die Ankündigung der Übernahme und die Anlage; es enthält keine Finanzberichte oder Details über die erwarteten Auswirkungen auf Umsatz, Aufwendungen oder Operationen.
HealthStream, Inc. قدمت نموذج 8-K يعلن أن الشركة في 8 أكتوبر 2025 أصدرت بياناً صحفياً يعلن عن استحواذها على Virsys12, LLC، وهي شركة ذات مسؤولية محدودة في ولاية تينيسي. يذكر الملف أن البيان الصحفي مرفق كالمعيار 99.1 ومدمج بالإشارة. لا يتم الكشف عن أي شروط مالية أو سعر شراء أو تغييرات في الإدارة أو التوجيه في الملف. الوثيقة محدودة بالإعلان عن الاستحواذ والملحق؛ ولا تتضمن بيانات مالية أو تفاصيل عن الأثر المتوقع على العوائد أو النفقات أو العمليات.
HealthStream, Inc. 已提交一份 8-K，称公司在 2025 年 10 月 8 日 发布新闻稿，宣布收购 Virsys12, LLC，这是一家位于田纳西州的有限责任公司。 filing 指出新闻稿作为 Exhibit 99.1 附件并通过引用并入。 filing 未披露任何财务条款、购买价格或管理层变动或指导方针的变动。该文件仅限于宣布收购及附件；不包含财务报表或关于交易对收入、支出或运营的预期影响的细节。
- Acquisition announced — HealthStream confirmed acquisition of Virsys12, LLC on October 8, 2025
- Formal disclosure — Press release filed as Exhibit 99.1, providing an official source for transaction details
- No financial terms disclosed — the filing includes no purchase price, consideration type, or funding details
- No impact metrics — the filing does not disclose expected effects on revenue, expenses, headcount, or integration timelines
Insights
TL;DR: HealthStream announced an acquisition of Virsys12 without financial details.
The filing confirms an acquisition occurred on October 8, 2025, and that the related press release is filed as Exhibit 99.1. This indicates a completed transaction or at least a formal announcement, which is a corporate development event that could affect product offerings or market position.
Key dependencies are the undisclosed purchase price, integration plan, and revenue or cost synergies; those items are not present in the filing and therefore cannot be assessed. Watch for subsequent filings or the Exhibit 99.1 press release to provide concrete metrics and timelines over the near term.
TL;DR: The 8-K is informational only and omits material financial specifics.
The report incorporates a press release by reference but contains no financial statements, pro forma information, or disclosures about the accounting treatment of the acquisition. Without such details, investors cannot evaluate the deal's immediate impact on results or balance sheet metrics.
Expect potential follow-up disclosures: either an 8-K with financial effects, a Form 8-K amending disclosures, or notes in the next periodic filing; these would clarify materiality within the next reporting cycle.
HealthStream, Inc. ha presentato una 8-K che comunica che, l'8 ottobre 2025, la società ha emesso un comunicato stampa annunciando l'acquisizione di Virsys12, LLC, una società a responsabilità limitata del Tennessee. La compilazione indica che il comunicato stampa è allegato come Exhibit 99.1 e incorporato per riferimento. Nel filing non vengono divulgati termini finanziari, prezzo di acquisto o cambiamenti nella gestione o nelle linee guida. Il documento è limitato all'annuncio dell'acquisizione e all'esibizione; non include bilanci o dettagli sull'impatto previsto sulla redditività, sulle spese o sulle operazioni.
HealthStream, Inc. presentó un 8-K informando que el 8 de octubre de 2025 la empresa emitió un comunicado anunciando la adquisición de Virsys12, LLC, una sociedad de responsabilidad limitada de Tennessee. La presentación indica que el comunicado de prensa está adjunto como el Exhibit 99.1 e incorporado por referencia. En la presentación no se divulgan términos financieros, precio de compra ni cambios en la dirección o en las directrices. El documento se limita al anuncio de la adquisición y al exhibit; no incluye estados financieros ni detalles sobre el impacto esperado en ingresos, gastos u operaciones.
HealthStream, Inc.은 2025년 10월 8일에 회사가 보도자료를 발표하여 Virsys12, LLC를 인수했다고 발표하는 8-K를 제출했습니다. 이는 Tennessee 주의 유한책임회사입니다. 제출 자료는 보도자료가 Exhibit 99.1로 첨부되어 있으며 참조에 의해 통합되어 있음을 명시합니다. 서류에는 재무 조건, 매입가, 경영진 변경 또는 가이드라인의 변경이 공시되지 않았습니다. 문서는 인수 발표 및 첨부 문서에 한정되며, 재무제표나 거래가 매출, 비용 또는 운영에 미칠 예상 영향에 대한 세부사항은 포함되어 있지 않습니다.
HealthStream, Inc. a déposé un 8-K indiquant qu'le 8 octobre 2025 la société a publié un communiqué annonçant l'acquisition de Virsys12, LLC, une société à responsabilité limitée du Tennessee. Le dépôt précise que le communiqué de presse est joint en tant que pièce 99.1 et incorporé par référence. Aucune condition financière, prix d'achat ou changement de direction ou d'orientation n'est divulgué dans le dépôt. Le document se limite à l'annonce de l'acquisition et à la pièce jointe; il ne comprend pas les états financiers ni les détails sur l'impact prévu sur les revenus, les dépenses ou les opérations.
HealthStream, Inc. hat eine 8-K eingereicht, in der am 8. Oktober 2025 ein Pressemitteilung veröffentlicht wurde, die den Erwerb von Virsys12, LLC, einer Tennessee Limited Liability Company, ankündigt. Die Einreichung gibt an, dass die Pressemitteilung als Exhibit 99.1 beigefügt und durch Bezugnahme aufgenommen ist. Im Filing werden keine finanziellen Bedingungen, kein Kaufpreis oder Änderungen an der Geschäftsführung oder dem Guidance offengelegt. Das Dokument beschränkt sich auf die Ankündigung der Übernahme und die Anlage; es enthält keine Finanzberichte oder Details über die erwarteten Auswirkungen auf Umsatz, Aufwendungen oder Operationen.
FAQ
What did HealthStream (HSTM) announce on October 8, 2025?
Does the 8-K disclose the purchase price for Virsys12?
Are there any financial statements or pro forma results included for the acquisition?
Where can investors find more details about the Virsys12 acquisition?
Did the filing indicate any management changes related to the acquisition?
